Terms: = Colorectal cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C
61 results:
1. Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1.
Ha JL; Kaser E; Guan T; Mayberry TG; Smith LA; D'mello K; Bai Q; Wakefield MR; Dong L; Fang Y
Med Oncol; 2024 Jan; 41(3):65. PubMed ID: 38281234
[TBL] [Abstract] [Full Text] [Related]
2. Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study.
Rijken A; van de Vlasakker VCJ; Simkens GA; Rovers KP; van Erning FN; Koopman M; Verhoef C; de Wilt JHW; de Hingh IHJT
Clin Exp Metastasis; 2023 Aug; 40(4):289-298. PubMed ID: 37209222
[TBL] [Abstract] [Full Text] [Related]
3. Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation.
Lin YS; Chiang SF; Chen CY; Hong WZ; Chen TW; Chen WT; Ke TW; Yang PC; Liang JA; Shiau AC; Chao KSC; Huang KC
Cancer Immunol Immunother; 2023 Jul; 72(7):2283-2297. PubMed ID: 36881132
[TBL] [Abstract] [Full Text] [Related]
4. A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic colorectal cancer and Other cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study.
Tan L; Tran B; Tie J; Markman B; Ananda S; Tebbutt NC; Michael M; Link E; Wong SQ; Chandrashekar S; Guinto J; Ritchie D; Koldej R; Solomon BJ; McArthur GA; Hicks RJ; Gibbs P; Dawson SJ; Desai J
Clin Cancer Res; 2023 Mar; 29(6):1017-1030. PubMed ID: 36638198
[TBL] [Abstract] [Full Text] [Related]
5. Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study.
Ballester MP; Mesonero F; Flórez-Diez P; Gómez C; Fuentes-Valenzuela E; Martín N; Senosiain C; Vela M; Fernández-Clotet A; Pérez P; Rubín de Célix C; Calviño-Suárez C; Hermida B; Muñoz R; González-Vivo M; Brunet E; Jiménez N; Botella B; Yebra J; Suárez-Ferrer C; Bouhmidi A; López-Serrano A; Ponferrada Á; Dueñas C; Mínguez M;
Aliment Pharmacol Ther; 2022 Jun; 55(11):1402-1413. PubMed ID: 35224758
[TBL] [Abstract] [Full Text] [Related]
6. Effects of Goshajinkigan (TJ-107) for oxaliplatin-induced peripheral neurotoxicity using the functional assessment of cancer therapy/gynecologic oncology group 12-item neurotoxicity questionnaire in a Phase II, multicenter, randomized, double-blind, placebo-controlled trial.
Aoyama T; Morita S; Kono T; Hata T; Mishima H; Sakamoto J
J Cancer Res Ther; 2021; 17(6):1473-1478. PubMed ID: 34916380
[TBL] [Abstract] [Full Text] [Related]
7. [Adherence to adjuvant with therapy imatinib in patients with gastrointestinal stromal tumor: a national multi-center cross-sectional study].
Zhang P; Zhang J; Zhang B; Yang WC; Hu JB; Sun XF; Zhai G; Qian HR; Li Y; Xu H; Feng F; Wu XY; Liu HL; Liu HJ; Qiu HB; Wu XJ; Zhou YB; Shen KT; Kou YW; Fu Y; Jie ZG; Zou XM; Cao H; Gao ZD; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):775-782. PubMed ID: 34530558
[No Abstract] [Full Text] [Related]
8. Estimation of overdiagnosis in colorectal cancer screening with sigmoidoscopy and faecal occult blood testing: comparison of simulation models.
Wieszczy P; Kaminski MF; Løberg M; Bugajski M; Bretthauer M; Kalager M
BMJ Open; 2021 Apr; 11(4):e042158. PubMed ID: 33853794
[TBL] [Abstract] [Full Text] [Related]
9. Management of intra- and postoperative complications during TEM/TAMIS procedures: a systematic review.
Serra-Aracil X; Badia-Closa J; Pallisera-Lloveras A; Mora-López L; Serra-Pla S; Garcia-Nalda A; Navarro-Soto S
Minerva Surg; 2021 Aug; 76(4):343-349. PubMed ID: 33433070
[TBL] [Abstract] [Full Text] [Related]
10. Terminal deoxynucleotidyl transferase based signal amplification for enzyme-linked aptamer-sorbent assay of colorectal cancer exosomes.
Huang Z; Lin Q; Ye X; Yang B; Zhang R; Chen H; Weng W; Kong J
Talanta; 2020 Oct; 218():121089. PubMed ID: 32797865
[TBL] [Abstract] [Full Text] [Related]
11. A prospective multicenter phase II study on the efficacy and safety of dasatinib in the treatment of metastatic gastrointestinal stromal tumors failed by imatinib and sunitinib and analysis of NGS in peripheral blood.
Zhou Y; Zhang X; Wu X; Zhou Y; Zhang B; Liu X; Wu X; Li Y; Shen L; Li J
Cancer Med; 2020 Sep; 9(17):6225-6233. PubMed ID: 32677196
[TBL] [Abstract] [Full Text] [Related]
12. Loss of the nuclear Wnt pathway effector TCF7L2 promotes migration and invasion of human colorectal cancer cells.
Wenzel J; Rose K; Haghighi EB; Lamprecht C; Rauen G; Freihen V; Kesselring R; Boerries M; Hecht A
Oncogene; 2020 May; 39(19):3893-3909. PubMed ID: 32203164
[TBL] [Abstract] [Full Text] [Related]
13. Postoperative chemotherapy improves survival in patients with resected high-risk Stage II colorectal cancer: results of a systematic review and meta-analysis.
Simillis C; Singh HKSI; Afxentiou T; Mills S; Warren OJ; Smith JJ; Riddle P; Adamina M; Cunningham D; Tekkis PP
Colorectal Dis; 2020 Oct; 22(10):1231-1244. PubMed ID: 31999888
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
[TBL] [Abstract] [Full Text] [Related]
15. Feasibility and economic assessment of chromocolonoscopy for detection of proximal serrated neoplasia within a population-based colorectal cancer screening programme (CONSCOP): an open-label, randomised controlled non-inferiority trial.
Hurt C; Ramaraj R; Farr A; Morgan M; Williams N; Philips CJ; Williams GT; Gardner G; Porter C; Sampson J; Hillier S; Heard H; Dolwani S;
Lancet Gastroenterol Hepatol; 2019 May; 4(5):364-375. PubMed ID: 30885505
[TBL] [Abstract] [Full Text] [Related]
16. Metachronous Neoplasias Arise in a Higher Proportion of Colon Segments From Which Large Polyps Were Previously Removed, and Can be Used to Estimate Incomplete Resection of 10-20 mm colorectal Polyps.
Adler J; Toy D; Anderson JC; Robertson DJ; Pohl H
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2277-2284. PubMed ID: 30768963
[TBL] [Abstract] [Full Text] [Related]
17. Macrophage migration inhibitory factor serves a pivotal role in the regulation of radiation-induced cardiac senescencethrough rebalancing the microRNA-34a/sirtuin 1 signaling pathway.
Hu Y; Xia W; Hou M
Int J Mol Med; 2018 Nov; 42(5):2849-2858. PubMed ID: 30226567
[TBL] [Abstract] [Full Text] [Related]
18. Complementary Medicine, Refusal of Conventional cancer Therapy, and Survival Among Patients With Curable cancers.
Johnson SB; Park HS; Gross CP; Yu JB
JAMA Oncol; 2018 Oct; 4(10):1375-1381. PubMed ID: 30027204
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of the Lipid Profile in Patients with colorectal cancer in Advanced Stages.
de Figueiredo Junior AG; Serafim PVP; de Melo AA; Felipe AV; Lo Turco EG; da Silva IDCG; Forones NM
Asian Pac J Cancer Prev; 2018 May; 19(5):1287-1293. PubMed ID: 29802561
[TBL] [Abstract] [Full Text] [Related]
20. The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma.
Stein CK; Pawlyn C; Chavan S; Rasche L; Weinhold N; Corken A; Buros A; Sonneveld P; Jackson GH; Landgren O; Mughal T; He J; Barlogie B; Bergsagel PL; Davies FE; Walker BA; Morgan GJ
Oncotarget; 2017 Apr; 8(17):27854-27867. PubMed ID: 28427158
[TBL] [Abstract] [Full Text] [Related]
[Next]
